Pennsylvania has long had one of the highest death rates from drug overdose in the US. But new studies suggest counties throughout the state have different rates of opioid deaths.
Academic rigour, journalistic flair
Articles on Fentanyl
Displaying 1 - 20 of 35 articles
As British Columbia begins a new era in drug policy, the drug poisoning crisis continues without an end in sight.
Like clockwork, September crime news is often cast as an ominous sign of what could happen on Halloween.
People in Nigeria are creating new drugs either because they can’t afford more traditional narcotics, because they’re not controlled or because they’re strong.
Fentanyl’s wide availability in the drug supply has led to an increase in unintentional overdoses. While prevention strategies are available, limited availability stymies their use.
People are dying from using a toxic drug supply. Safer supply and other approaches that listen to the needs of people who use drugs are critical to saving lives and addressing the opioid crisis.
The number of fatal drug overdoses in the US over a 12-month period has surpassed 100,000 for the first time. Fentanyl is the main driver of the spike in deaths.
False narratives about drug addiction and policies that are not supported by research are deepening the overdose epidemic in the US.
Fentanyl adulteration led to the replacement of heroin in the unregulated drug supply of British Columbia. Now that benzodiazepines are present in many opioids, are we headed towards a ‘new normal?’
While the COVID-19 pandemic raged on, the opioid epidemic got worse as drug overdose deaths soared. New research proposes a way to chemically modify opioids to reduce the risk of addiction.
Across the country, overdose deaths have spiked during the COVID-19 pandemic.
Social media makes it easy to spread ‘fake news’.
COVID-19 plagues an overtaxed opioid addiction treatment system.
Illicit and legitimate trade are closely connected, so how come one seems to be rising while the other has plunged?
Prices are surging amid shortages and panic-buying – and we could soon be facing a public health disaster.
Fentanyl has been a prime culprit in the opioid crisis in the United States. It’s now turning up in cocaine and methamphetamine in New South Wales.
From colonial poppy fields to pharmatrash, southern Africa offers a fascinating history of drug regimes – one that helps us make sense of drug policies and legislation today.
In the midst of a public health crisis, with increasing rates of death from opioid overdose, the Ontario government is clawing back life-saving measures.
A policy response focused on reducing prescription opioids will not resolve North America’s opioid crisis. And it is hurting many adults who live with otherwise unbearable chronic pain.
Most medical historians agree that one of the most important advances in medicine was the use of ether to numb pain during surgery. Just who deserves credit for this has been another story.
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Associate Professor, Mental Health and Addiction, Rural Health Research Institute, Charles Sturt University
-
Research Scientist, BC Centre on Substance Use and Assistant Professor in the Division of AIDS, Department of Medicine, University of British Columbia
-
PhD Student, School of Population and Public Health, University of British Columbia
-
Emeritus Professor, Australian National University
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professor of Sociology and Criminal Justice, University of Delaware
-
Associate Professor of Population Health, New York University
-
Senior lecturer, Australian National University
-
Director Leverhulme Research Centre for Forensic Science, University of Dundee
-
Research associate, University of Pretoria
-
Professor in Substance Use, Liverpool John Moores University
-
Tony Walker is a Friend of The Conversation.
Vice-Chancellor's Fellow, La Trobe University
-
Professor of Geography, Penn State
-
Postdoctoral Fellow and clinician-scientist with the BC Centre on Substance Use and UBC Faculty of Medicine, University of British Columbia
